Who Paid My Doc
Maria Markarian
Interventional Cardiology Lansing, MI Doctor of Osteopathy
NPI 1861490641 CMS profile 39384
405 W Greenlawn Ave, Ste 400, Lansing, MI 48910
General payments
$22,207
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Maria Markarian of Lansing, MI is reported in the CMS Open Payments database as having received $22,207 across 877 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 77th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $2,195 | 97 | |
| 2024 | General | $2,295 | 120 | |
| 2023 | General | $3,378 | 112 | |
| 2022 | General | $3,114 | 133 | |
| 2021 | General | $3,853 | 146 | |
| 2020 | General | $2,484 | 111 | |
| 2019 | General | $4,888 | 158 |
Beside peers
- Maria Markarian
- Interventional Cardiology median
- Middle half of Interventional Cardiology
- National median
In program year 2025, general payments to Maria Markarian were reported at $2,195. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.
Show as a table
| Year | Maria Markarian | Interventional Cardiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $4,888 | $1,097 | $329–$3,048 | $163 |
| 2020 | $2,484 | $473 | $161–$1,480 | $114 |
| 2021 | $3,853 | $677 | $233–$1,827 | $132 |
| 2022 | $3,114 | $978 | $333–$2,724 | $149 |
| 2023 | $3,378 | $1,136 | $382–$2,986 | $160 |
| 2024 | $2,295 | $1,181 | $395–$3,326 | $164 |
| 2025 | $2,195 | $1,092 | $366–$3,019 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 50 drugsPart D claims
2,476
Drug cost
$962,636
Branded share of claims
37.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 159 | $248,200 | |
| Xarelto Rivaroxaban | Brand | 196 | $234,218 | |
| Entresto Sacubitril/Valsartan | Brand | 75 | $117,883 | |
| Repatha Sureclick Evolocumab | Brand | 49 | $58,678 | |
| Nexletol Bempedoic Acid | Brand | 36 | $36,811 | |
| Verquvo Vericiguat | Brand | 15 | $28,085 | |
| Multaq Dronedarone Hcl | Brand | 11 | $25,752 | |
| Ozempic Semaglutide | Brand | 16 | $25,227 | |
| Jardiance Empagliflozin | Brand | 14 | $24,706 | |
| Nexlizet Bempedoic Acid/Ezetimibe | Brand | 23 | $23,694 |
The 10 drugs with the highest cost, of 50 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.
Records
877 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Interventional Cardiology in Michigan
Amir Kaki
Interventional Cardiology · Detroit, MI
Tamam Mohamad
Interventional Cardiology · Detroit, MI
Paul Grossman
Interventional Cardiology · Ann Arbor, MI
Jason Ricci
Interventional Cardiology · Petoskey, MI
Tim Fischell
Interventional Cardiology · Kalamazoo, MI
Mir Basir
Interventional Cardiology · Detroit, MI
Related records
Interventional Cardiology in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Interventional Cardiology
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.